Upload Avatar (500 x 500)
周宇峰
zyf@scau.edu.cn
英语, 中文
广东
华南农业大学
Veterinary Medicine
  • 2017.08-2018.08 联合培养博士: 加州大学洛杉矶分校 (UCLA)
  • 2013.09-2018.12 基础兽医学博士: 华南农业大学
  • 2009.09-2013.06 动物医学学士: 华南农业大学
  • 在国际和国内专业学术期刊发表论文30余篇
  • 以第一作者或通讯作者发表SCI收录论文15篇
  • 获得华人抗菌药物敏感性试验委员会ChiCAST荣誉贡献个人奖
  • 2019.01-至今 - 华南农业大学 - 副教授
  • 华人抗菌药物敏感性试验委员会ChiCAST荣誉贡献个人奖
兽医药代动力学
药动/药效学同步模型
抗菌药敏感性折点
细菌耐药控制策略
  • Pharmacodynamic Target Assessment and PK/PD Cutoff Determination for Gamithromycin Against Streptococcus suis in Piglets, Wang RL, Liu P, Chen XF, Yao X, Liao XP, Liu YH, Sun J, Zhou YF, 2022
  • Comparison of PK/PD Targets and Cutoff Values for Danofloxacin Against Pasteurella multocida and Haemophilus parasuis in Piglets, Zhou YF, Sun Z, Wang RL, Li JG, Niu CY, Li XA, Feng YY, Sun J, Liu YH, Liao XP, 2022
  • Activity of Tigecycline or Colistin in Combination with Zidovudine against Escherichia coli Harboring tet(X) and mcr-1, Zhou YF, Liu P, Dai SH, Sun J, Liu YH, Liao XP, 2021
  • In Vivo Pharmacodynamic Target Assessment of Antofloxacin against Streptococcus pneumoniae and Staphylococcus aureus in a Neutropenic Murine Pneumonia Model, Zhou YF, Liu P, Dai SH, Sun J, Liu YH, Liao XP, 2020
  • Linezolid and Rifampicin Combination to Combat cfr-Positive Multidrug-Resistant MRSA in Murine Models of Bacteremia and Skin and Skin Structure Infection, Zhou YF, Li L, Tao MT, Sun J, Liao XP, Liu YH, Xiong YQ, 2020
  • Colistin Combined With Tigecycline: A Promising Alternative Strategy to Combat Escherichia coli Harboring bla NDM-5 and mcr-1, Zhou YF, Liu P, Zhang CJ, Liao XP, Sun J, Liu YH, 2020
  • Epidemiological and PK/PD cutoff values determination and PK/PD-based dose assessment of gamithromycin against Haemophilus parasuis in piglets, Zhou YF, Bu MX, Liu P, Sun J, Liu YH, Liao XP, 2020
  • Increased activity of linezolid in combination with rifampicin in a murine pneumonia model due to MRSA, Zhou YF, Xiong YQ, Tao MT, Li L, Bu MX, Sun J, Liao XP, Liu YH, 2018
  • In vivo bioluminescent monitoring of therapeutic efficacy and pharmacodynamic target assessment of antofloxacin against Escherichia coli in a neutropenic murine thigh infection model, Zhou YF, Tao MT, He YZ, Sun J, Liu YH, Liao XP, 2018
  • Increased activity of colistin in combination with amikacin against Escherichia coli co-producing NDM-5 and MCR-1, Zhou YF, Tao MT, Feng Y, Yang RS, Liao XP, Liu YH, Sun J, 2017
  • In vivo pharmacokinetic and pharmacodynamic profiles of antofloxacin against Klebsiella pneumoniae in a neutropenic murine lung infection model, Zhou YF, Tao MT, Huo W, Liao XP, Sun J, Liu YH, 2017
  • Pharmacodynamic evaluation and PK/PD-based dose prediction of tulathromycin: a potential new indication for Streptococcus suis infection, Zhou YF, Peng HM, Bu MX, Liu YH, Sun J, Liao XP, 2017
  • Pharmacokinetic/ pharmacodynamic correlation of cefquinome against experimental catheter-associated biofilm infection due to Staphylococcus aureus, Zhou YF, Shi W, Yu Y, Tao MT, Xiong YQ, Sun J, Liu YH, 2016
  • Ex vivo pharmacokinetic/pharmacodynamic relationship of valnemulin against Clostridium perfringens in plasma, the small intestinal and caecal contents of rabbits, Zhou YF, Yu Y, Sun J, Tao MT, Zhou WJ, Li X, Liao XP, Liu YH, 2016
  • Pharmacokinetics, bioavailability and PK/PD relationship of cefquinome for Escherichia coli in Beagle dogs, Zhou YF, Zhao DH, Yu Y, Yang X, Shi W, Peng YB, Liu YH, 2015
兽医 药代动力学 药效学 建模 抗菌 敏感性 折点 细菌 耐药 控制

联系我们

欢迎与我们交流!
* Required
* Required
* Required
* Invalid email address
提交此表单,即表示您同意 IoT ONE 可以与您联系并分享洞察和营销信息。
不,谢谢,我不想收到来自 IoT ONE 的任何营销电子邮件。
提交

感谢您的信息!
我们会很快与你取得联系。